key: cord-0973078-ifsk0ep1
authors: Guohu, H.; Qing, G.; Qing, M.
title: Spread dynamics of SARS-CoV-2 epidemic in China: a phylogenetic analysis
date: 2020-05-25
journal: nan
DOI: 10.1101/2020.05.20.20107854
sha: d0d7ebdfa37bbd3f66c09e2027095649ac2f6cf3
doc_id: 973078
cord_uid: ifsk0ep1

To reveal the detailed spread dynamics of SARS-CoV-2 epidemic in China, a phylogenetic analysis was performed by the Bayesian inference framework tool. 233 strains were retrieved from confirmed cases in China until March 31, 2020. The tMRCA of SARS-CoV-2 strains in China could be traced back to December 9, 2019. According to the effective population size curve reconstructed by Skyline model, this research revealed the influence of travel ban measures on the effective population size in China. Furthermore, we divided the epidemic process of SARS-CoV-2 in China into 4 stages according to the effective population size curve. With the Bayesian stochastic search variable selection method, phylogeographical reconstruction detailedly described the geographic spread behavior of SARS-CoV-2 in each stage and confirmed the importance of travel ban in blocking SARS-CoV-2 cross-regional spread. This article summarizes the influence of prevention and control measures in China, which has a positive impact on the world.

Coronavirus (CoV) is a broadly distributed zoonotic virus, some species of them can cause human disease. In a long time, it was generally believed that CoV spread with small-scale and caused mild symptoms in immunocompetent individuals (1) .

However, the outbreak of severe acute respiratory syndrome coronavirus (SARS-CoV) (2) and Middle East respiratory syndrome coronavirus (MERS-CoV) (3) in the early 21st century, indicated that coronavirus may cause large-scale outbreaks of serious disease.

Since December 2019, an acute respiratory infectious disease caused by a novel coronavirus (4) spread throughout the world in a short time. WHO named it severe acute respiratory syndrome coronavirus 2(SARS-CoV-2), because of a close genetic relationship with SARS-CoV. Some SARS-CoV-2 infected individuals are suffering from Corona Virus Disease 2019 (COVID- 19) , which not only cause respiratory system disease but also multiple organs dysfunction (5, 6) . According to the clinical published data, millions of people were infected, and the inflection point of the epidemic has not yet arrived.

As the first country outbreak the SARS-CoV-2 epidemic, China confronted a great challenge in prevention and control. Although there was no experience to refer, a series of strong and effective response measures were implemented in the early period of SARS-CoV-2 epidemic. According to the published data (7) from December 2019 to March 2020, the epidemic was effectively curbed in china, however, the global epidemic was not controlled. Summing up China's experience is beneficial to global prevention and control.

It was generally accepted that the travel ban was an important prevention and control measure taken by China. on January 23, 2020, Hubei Province activated the Level-I alert of public health incidents, and the other Provinces, municipalities, autonomous regions in the China mainland activated the Level -I alert, in the following week. The national response appeared to delay the growth of SARS-CoV-2 infected (8) . Although the clinical published data was detailed and reliable, probably it was not accurately reflected the number of infections and the scale of geographic . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 25, 2020. . https://doi.org/10.1101/2020.05.20.20107854 doi: medRxiv preprint spread of SARS-CoV-2, because of the incubation period and lack of nucleic acid detection capacity in the early-period.

To explore more details of SARS-CoV-2 epidemic in China, we used the molecular epidemiological method to investigate the spread dynamics of SARS-CoV-2. Bayesian inference through a Markov chain Monte Carlo (MCMC) framework was employed for estimating the evolutionary characteristic parameters of SARS-CoV-2 and an appropriate non-parametric coalescent model was used to calculate the effective population size (Ne), which was an important supplement in estimating the number of infections besides the clinical published data. Based on the calculation results of evolutionary parameters, we reconstructed a phylogeographical distribution among different regions of China, which indicated the dynamic distribution of SARS-CoV-2 in China.

Spike (S) gene was defined as the target gene in this research. NCBI and GISAID (9) databases were used to download the data as of March 31, 2020. All SARS-CoV-2 sequences were collected from China in human hosts with the full length of S gene. Those sequences without high coverage sequencing or accurate regional description were eliminated. we also eliminated the duplicate data with the same origin information and nucleic acid in NCBI and GISAID databases. The rest 235 SARS-CoV-2 sequences were performed the multiple alignments by CLUSTAL X program (10) and trimmed into a full-length S gene of 3822 nt. LR757997 and EPI_ISL_417181 were eliminated because of containing over 2% inaccurate nucleic acids in S gene. 233 sequences with 3822nt were selected for this study, including 29 Clinical published data was provided by a open-source R package named nCov2019 (7) , which described the real-time statistic data with explicit geographic information. New daily confirmed cases data was extracted, and divided into Hubei . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 25, 2020. . https://doi.org/10.1101/2020.05.20.20107854 doi: medRxiv preprint Province data, national data, and national data without Hubei Province. Due to the modification of the diagnostic criteria in Wuhan, new daily confirmed cases increased significantly on February 12 and 13, 2020. The data of two days above was eliminated.

The trend line was estimated with gamma distribution by R package ggplot2.

Bayesian inference through a MCMC framework implemented by BEAST v1.10.4 packages (11) was employed to analyze the evolutionary details of S gene, and Ne was reconstructed by a non-parametric coalescent model Skyline (12) . General Time Reversible (GTR) was selected as the nucleotide substitution model by calculated AIC score using jModeltest v1.9.1 program (13) . Based on the previous genetic analysis (14) (15) (16) , an uncorrelated lognormal molecular clock (17) was assumed as the optimization clock mode, given a continuous-time Markov chain reference prior (18) . Collected time of almost sequences was reliable to certainty day except MN908947, which was re-estimated as a prior from December 26 to 31, 2019 (19) .

Three independent computing processes were performed, and in each process, MCMC chains were set to 200 million and sampling computed every 10000 steps. The output files generated by bayesian computing were discarded the first 10% as burn-in and then combined by LogCombiner tool in BEAST v1.10.4 packages. Tracer software v1.7.1 (20) was used to diagnose MCMCs output and estimate Ne curve with another 10% burn-in. effective sample sizes (ESS) values greater than 200 for each estimated parameter were accepted.

To infer the geographical phylogenetic diffusion among the 15 discrete locations in China, we adopt an asymmetric continuous-time Markov chain (21) and inferred spatial-temporal linkage by using Bayesian stochastic search variable selection (BSSVS) (21) . Nucleotide substitution model and tree prior method were kept as GTR and Skyline respectively. The result of time-resolved phylogenetic analyses provided explicit prior information in MN908947 height, uncorrelated lognormal molecular clock setting, and tree root height presupposition. In this computing process we replaced molecular clock rate as a log-normal prior mean and standard deviation value.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. file by spreaD3 v0.9.7 (22) , which was viewed in Google Earth v7.1.8.

The mean value of S gene evolutionary rate was inferred to 4.0520 To display the geographic spread of SARS-CoV-2 strains in China more clearly, a visualized dynamic graph was generated by spreaD3 and viewed by Google Earth.

We displayed the inter-regional spread situation in some key time points of the 4 epidemic stages we divided (Fig. 3) . In the stage , although the increased trend of strain was not detected, the inter-regional spread to Guangdong existed (Fig. 3A) , which was probably considered as the first region influenced by SARS-CoV-2 outside

Hubei. The analysis of viral Ne had been confirmed the importance of stage , and the . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 25, 2020. . https://doi.org/10.1101/2020.05.20.20107854 doi: medRxiv preprint result of geographical reconstruction revealed the complication of SARS-CoV-2 strains spread in China (Fig. 3B) , compared with stage (Fig. 3C) , the inter-regional propagation path had not been changed. Even the observation time was extended to the stage , the inter-regional cross mode remained stable, although two inter-regional spread path was observed, considered with the population migration had been almost paused, we believed that those two suspicious spreads probably be related to sampling error.

SARS-CoV-2 has caused a serious public health event in the world since December 2019. The epidemic has a huge negative impact on the global economy and human health (23, 24) . Chloroquine (25) and Remdesivir (26) are considered as potential specific drugs, but the efficacy needs to be confirmed by more clinical trials (27) . Safety, effectiveness and virus variation are still bottlenecks to the vaccine developed (28) . As there is currently neither a vaccine nor a specific drug, formulating effective virus spread blocking measures probably is an achievable option. S gene codes the SARS-CoV-2 spike glycoprotien and plays an important role in human susceptibility (29) , antibody marker (30) , antiviral target (31) and vaccine design (32) .

So We choose the S gene as the target in this research. The molecular clock rate estimating provide a vital practical basis for the further study of the S gene evolutionary characteristics. The most recent common ancestor of China strains was . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 25, 2020. . https://doi.org/10.1101/2020.05.20.20107854 doi: medRxiv preprint traced to 9 Dec 2019, which was very similar to Li`s research (33) . Considered with the incubation period (34) , we infer that the first patient hospitalized on December 12, 2019 (19) . It probably is close to the China strains ancestor.

Dividing the spread process into 4 stages can reveals the changes of viral Ne and geographic spread behavior in each stage distinctly.Combined with the preventive and control measures implemented in China, the importance of travel ban in blocking the spread of SARS-CoV-2 is revealed. We can not accurately assess the influence of SARS-CoV-2 on China without travel ban. However, the research demonstrates that the SARS-CoV-2 has spread to almost all regions in this research in the early period.

After travel ban implemented on January 23,2020, in 3 days, the viral Ne declined rapidly, and inter-regional spread almost was blocked. But base on the clinical published data, this change detail was not observed, and the inflection point was observed until mid-February 2020. This research provides a good example that the viral epidemiological survey based on phylogenetic analysis probably provides more information. During the latest two months, there is not any large-scale spread of SARS-CoV-2 in China, which is closely related to the continued travel ban.

Considered with the number of tourists during the Spring Festival in other years, the travel ban in 2020 markedly reduced the number of domestic spread and potential exportations, which is not only important to China but also the whole world.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 25, 2020. . https://doi.org/10.1101/2020.05.20.20107854 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 25, 2020. . https://doi.org/10.1101/2020.05.20.20107854 doi: medRxiv preprint

Origin and evolution of pathogenic coronaviruses

Coronavirus as a possible cause of severe acute respiratory syndrome

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

A Novel Coronavirus from Patients with Pneumonia in China

Liver injury in COVID-19: management and challenges. The lancet Gastroenterology & hepatology

COVID-19 and the cardiovascular system

Open-source analytics tools for studying the COVID-19 coronavirus outbreak. medRxiv

An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China

disease and diplomacy: GISAID's innovative contribution to global health. Global challenges

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic acids research

Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus evolution

Bayesian coalescent inference of past population dynamics from molecular sequences

jModelTest: phylogenetic model averaging

Evolutionary history of the closely related group 2 coronaviruses: porcine hemagglutinating encephalomyelitis virus, bovine coronavirus, and human coronavirus OC43

Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. mBio

The recent ancestry of Middle East respiratory syndrome coronavirus in Korea has been shaped by recombination. Scientific reports

Relaxed phylogenetics and dating with confidence

Bayesian analysis of elapsed times in continuous -time markov chains

A new coronavirus associated with human respiratory disease in China

Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7. Systematic biology

Bayesian phylogeography finds its roots

Interactive Visualization of Spatiotemporal History and Trait Evolutionary Processes

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical Characteristics of Coronavirus Disease 2019 in China

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Hopes rise for coronavirus drug remdesivir

Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature reviews Drug discovery

The SARS-CoV-2 Vaccine Pipeline: an Overview. Current tropical medicine reports

Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations

Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Coronavirus membrane fusion mechanism offers a potential target for antiviral development

Site-specific glycan analysis of the SARS-CoV-2 spike

Bayesian phylodynamic inference on the temporal evolution and global transmission of SARS-CoV-2. The Journal of infection

Thanks to the researchers who share the genome data of SARS-CoV-2 to GISAID and NCBI.Availability of data and materials:

All data generated or analyzed during this study are included in this published article.

HGH was the major contributor in designing the research, performing phylogenetic analyses and writing the manuscript. GQ collated and analyzed the sequence information and clinical published data. MQ performed the phylogeographical reconstruction and supervised the study. All authors have read and approved the final manuscript.

Not applicable.

Not applicable.

The authors declare that they have no competing interests.. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted May 25, 2020. . https://doi.org/10.1101/2020.05.20.20107854 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 25, 2020. . https://doi.org/10.1101/2020.05.20.20107854 doi: medRxiv preprint Apr 20.. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 25, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 25, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 25, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted May 25, 2020. . https://doi.org/10.1101/2020.05.20.20107854 doi: medRxiv preprint